Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.3.13 (
lysyl oxidase
)
1,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Food dispersions have become essential vehicles to carry and deliver functional ingredients such as bioactive compounds, flavors, antimicrobials, antioxidants, colors and vitamins. Most of these systems are thermodynamically unstable tending to break down over time. Much research has therefore been carried out to develop methodologies to improve their long-term stability. In this review, we will introduce readers to a new approach that has been developed over the past years to stabilize food dispersions, i.e. by use of various enzymes. First, basic design principles of modern food dispersions including conventional emulsions, multiple emulsions, multilayered emulsions, solid lipid particle suspensions, and liposomes are discussed. Enzymes able to generate intra- and intermolecular crosslinks between proteins and/or polysaccharides will be reviewed and specific reactions catalyzed by, e.g., transglutaminase, laccase, tyrosinase, sulfhydryl oxidase,
glucose oxidase
, lipoxygenase, polyphenol oxidase, peroxidase, and
lysyl oxidase
will be highlighted. Finally, potential applications of this enzymatic approach in the food industry will be critically discussed.
...
PMID:Stabilization of food dispersions by enzymes. 2442 78
Hypoxia is a critical condition governing many aspects of cellular fate processes. The most common practice in hypoxic cell culture is to maintain cells in an incubator with controlled gas inlet (i.e., hypoxic chamber). Here, we describe the design and characterization of enzyme-immobilized hydrogels to create solution hypoxia under ambient conditions for in vitro cancer cell culture. Specifically,
glucose oxidase
(
GOX
) was acrylated and co-polymerized with poly(ethylene glycol)-diacrylate (PEGDA) through photopolymerization to form
GOX
-immobilized PEG-based hydrogels. We first evaluated the effect of soluble
GOX
on inducing solution hypoxia (O
2
<5%) and found that both unmodified and acrylated
GOX
could sustain hypoxia for at least 24h even under ambient air condition with constant oxygen diffusion from the air-liquid interface. However, soluble
GOX
gradually lost its ability to sustain hypoxia after 24h due to the loss of enzyme activity over time. On the other hand,
GOX
-immobilized hydrogels were able to create hypoxia within the hydrogel for at least 120h, potentially due to enhanced protein stabilization by enzyme 'PEGylation' and immobilization. As a proof-of-concept, this
GOX
-immobilized hydrogel system was used to create hypoxia for in vitro culture of Molm14 (acute myeloid leukemia (AML) cell line) and Huh7 (hepatocellular carcinoma (HCC) cell line). Cells cultured in the presence of
GOX
-immobilized hydrogels remained viable for at least 24h. The expression of hypoxia associated genes, including carbonic anhydrase 9 (CA9) and
lysyl oxidase
(
LOX
), were significantly upregulated in cells cultured with
GOX
-immobilized hydrogels. These results have demonstrated the potential of using enzyme-immobilized hydrogels to create hypoxic environment for in vitro cancer cell culture.
...
PMID:Enzyme-immobilized hydrogels to create hypoxia for in vitro cancer cell culture. 2828 22